Serratiopeptidase: Could excess fibrin be causing your back pain?

Millions of people worldwide suffer from chronic back pain. For decades, doctors and scientists have believed that inflammation is the root cause of this. And while inflammation certainly plays a major role, many of these same experts are coming to realize that excess fibrin – the protein deposits that often remain after a strain or injury has healed – is often the cause of prolonged back pain.                    

As we discussed earlier, serratiopeptidase – because of its ability to break down these excess protein, or fibrin deposits – can often succeed where “pain pills” fail. The Journal of International Medicine – a world-famous, highly regarded publication – has reported that serratiopeptidase (otherwise known as serrapeptase, or SP) “prevents swelling and fluid retention in a number of tissues, and its anti-inflammatory properties are superior to other enzymes.” 

Another opinion, published in the British Journal of Rheumatology, has many medical experts reconsidering their previous attitudes and theories regarding back pain. This study of chronic back pain sufferers (who were experiencing various types of back pain, including some “non-specific” varieties, or cases that were difficult to diagnose) found that fibrin deposits were, in fact, present in most instances. 

The study went on to note that whenever trauma to one’s back is experienced (be it a minor bump, strain from poor posture, over-exertion, or even from a lack of activity) the body’s natural reaction is inflammation, and subsequently, fibrin deposits or scar tissue. Usually the pain subsides once the inflamed area is cleared of fibrin by the body’s natural processes. 

The problem, however – which often prolongs and even worsens the pain – is that the excess fibrin sometimes stays “locked” to one’s spine. The conclusion of this landmark study was that, “… the persistence of fibrin could lead to the chronicity [or long-term worsening] of back pain …” 

So what is the upshot of all of this research? As we previously discussed, for chronic back-pain sufferers (or, for that matter, those who endure many types of chronic pain) serratiopeptidase may provide relief where over-the-counter, or even prescription painkillers fail to do more than give just a temporary “fix.” In fact, another authority has concluded that, “… besides reducing inflammation, one of serrapeptase’s most profound benefits is the reduction of pain due to its ability to block the release of pain-inducing amines (toxic, organic chemicals) from the inflamed tissues.” 

This means that not only can this amazing enzyme help relieve pain which already exists, but may even prevent the pain from occurring in the first place! Needless to say, this is great news for millions. We encourage you to check back soon for updates, where we’ll talk about other practical applications for serratiopeptidase, including relief from fibromyalgia, sinusitis, and other conditions.